RA
CNCE

Royce & Associates’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Royce & Associates’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,425
Closed -$21K – 1219
2018
Q3 		$21K Buy
1,425
+758
+114% +$11.9K ﹤0.01% 1150
2018
Q2 		$11K Buy
667
+344
+107% +$6.68K ﹤0.01% 1200
2018
Q1 		$7K Buy
+323
New +$7.18K ﹤0.01% 1228

Other funds holding CNCE

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return